University of Pittsburgh School of Medicine Graduate Program in Immunology has been awarded a National Cancer Institute Training Grant in Cellular and Molecular Mechanisms of Tumor Rejection. The program provides opportunities for pre-doctoral and post-doctoral trainees to become independent investigators in tumor immunology while working within a larger program that of research in basic cellular and molecular immunological mechanisms as well as human disease. The training faculty are: Joseph Ahearn, MD Molecular and cellular pathogenesis of SLE Simon Barratt-Boyes, PhD, DVM Primate dendritic cell biology Per H. Basse, MD, PhD, DMSci Tumor immunology Robert Binder, PhD Mechanisms of cross-priming of antigens during immune responses Lisa Borghesi, PhD Transcriptional control of V(D)J recombination Lisa Butterfield, PhD Tumor immunotherapy William Chambers, PhD Tumor immunology Kelly Stefano Cole, PhD HIV-1 and SIV infection and vaccination David Cooper, MD, PhD Xenotransplantation Albert Deleo, PhD Cancer immunotherapy Anthony Demetris, MD Transplantation immunology Rene Duquesnoy, PhD Transplantation immunology Louis Falo, Jr, MD, PhD Vaccine design Robert Ferris, MD, PhD Cancer immunology & immunotherapy Olivera Finn, PhD Human T-cell biology JoAnne Flynn, PhD Immunology & pathogenesis of Mycobacterium tuberculosis Nick Giannoukakis, PhD Gene & cell therapy for Type 1 & 2 Diabetes Mellitus Elieser Gorelik, MD, PhD Tumor immunology Maryam Hariri, PhD Prevention of allograft rejection Robert Hendricks, PhD Viral immunology Ronald Herberman, MD Natural killer cells Raphael Hirsch, MD Gene therapy for arthritis Pawel Kalinski, MD, PhD Tumor immunotherapy Lawrence Kane, PhD Akt kinase in T cell activation Jay Kolls, MD Mechanisms of lung host defenses Fadi Lakkis, MD Allorecognition in the innate immune system Adriana Larregina, MD, PhD Skin immunobiology Binfeng Lu, PhD Regulation of the MAP kinase pathway in the CD4+ cells Kyle McKenna, PhD Mechanisms of immune evasion by tumors developing within the eye Diana Metes, MD Immune responses to EBV in immunosupressed patients Christine Milcarek, PhD Immunoglobulin gene expression Ronald Montelaro, PhD HIV-1 and animal lentivirus antigenic variation Penelope Morel, MD Th1/Th2 regulation Adrian Morelli, MD, PhD DCs in peripheral tolerance and transplantation Sidney Morris, Jr, PhD Inflammation Michael Murphey-Corb, PhD SIV immunobiology Gerard Nau, MD, PhD Host-pathogen interactions, genomic approaches to gene expression analysis Karen Norris, PhD Immune evasion mechanisms of microbial pathogens Jon Piganelli, PhD Beta cell destruction in Type 1 diabetes Bruce Rabin, MD, PhD Immunopathology, psychoneuroimmunology Hannah Rabinowich, PhD Regulation of apoptosis in T lymphocytes Anuradha Ray Immunology of lung Prabir Ray, PhD Immunology of lung Todd Reinhart, ScD HIV and SIV molecular pathogenesis William Ridgway, MD Genetic control of autoimmune diabetes Ted Ross, PhD DNA vaccines for HIV-1 Russell Salter, PhD Antigen presentation in DCs Michael Shurin, MD, PhD Tumor immunology Walter Storkus, PhD NK cell and cytolytic T-lymphocyte antitumor targeting mechanisms Angus Thomson, PhD, DSc Transplantation tolerance Massimo Trucco, MD Genetics of diabetes Abbe Vallejo, PhD Immunobiology of aging Nikola Vujanovic, MD, PhD Immune response to oral cell cancer Theresa Whiteside, PhD Tumor immunology Zhaoyang You, PhD In vivo targeted vaccines for tumor immunotherapy Hassane Zarour, MD MHC class II tumor epitopes Adriana Zeevi Transplantation immunology Pre- and post-doctoral candidates with U.S. citizenship or with permanent resident status who are interested in joining the program should send a cover letter and CV to one of the listed investigators or to: Dr. Olivera Finn (PI) E1044 Biomedical Science Tower University of Pittsburgh School of Medicine 200 Lothrop St. Pittsburgh, PA 15261 The University of Pittsburgh is an equal opportunity employer committed to excellence through diversity.

Problems with this page? Contact us.